speb/financial-data huggingface dataset:
OBIO income_statement (quarterly, 2025-03-31) — +Operating Expense: 19745000.00
OBIO income_statement (quarterly, 2025-03-31) — +Total Revenue: 868000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5563000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 89000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1386000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 345449000.00
OBIO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 38235409.00
OBIO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.49
OBIO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 22261000.00
OBIO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -112000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2106000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 18348000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 49884000.00
OBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -296000.00
OBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 12999000.00
OBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -16616000.00
OBIO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 38000.00
OBIO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -132000.00
OBIO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -732000.00
OBIO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -202000.00
OBIO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 35000.00
OBIO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3000.00
OBIO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -990000.00
OBIO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 3000.00
OBIO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3913000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Common Stock: 4000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 16857000.00
OBIO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
OBIO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 44000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 4399000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Current Assets: 51903000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 590000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 590000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 3944000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 3944000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 15489000.00
OBIO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 83000.00
OBIO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 83000.00
OBIO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 38235409.00
OBIO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.49
OBIO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -18755000.00
OBIO income_statement (quarterly, 2025-03-31) — EBIT: -18921000.00
OBIO income_statement (quarterly, 2025-03-31) — EBITDA: -18838000.00
OBIO cash_flow (quarterly, 2025-03-31) — End Cash Position: 18348000.00
OBIO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -296000.00
OBIO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -16728000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 37000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4755000.00
OBIO income_statement (quarterly, 2025-03-31) — Gross Profit: 824000.00
OBIO income_statement (quarterly, 2025-03-31) — Interest Income: 166000.00
OBIO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 166000.00
OBIO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 358000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Inventory: 135000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 31195000.00
OBIO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 12999000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 2495000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 2495000.00
OBIO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
OBIO balance_sheet (quarterly, 2025-03-31) — Leases: 159000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1516000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 14338000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 15854000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 443000.00
OBIO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
OBIO income_statement (quarterly, 2025-03-31) — Net Income: -18755000.00
OBIO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -18755000.00
OBIO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -18755000.00
OBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -18755000.00
OBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -18755000.00
OBIO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -18755000.00
OBIO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -18755000.00
OBIO income_statement (quarterly, 2025-03-31) — Net Interest Income: 166000.00
OBIO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 13111000.00
OBIO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 166000.00
OBIO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -387000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Net PPE: 3369000.00
OBIO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -112000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 16857000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 10752000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 10752000.00
OBIO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -18838000.00
OBIO income_statement (quarterly, 2025-03-31) — Normalized Income: -18755000.00
OBIO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -16616000.00
OBIO income_statement (quarterly, 2025-03-31) — Operating Income: -18921000.00
OBIO income_statement (quarterly, 2025-03-31) — Operating Revenue: 868000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 38312512.00
OBIO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1795000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 37000.00
OBIO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 81000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1284000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 99000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Other Properties: 4153000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 31536000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Payables: 5563000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 9962000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 993000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
OBIO income_statement (quarterly, 2025-03-31) — Pretax Income: -18755000.00
OBIO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 91000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
OBIO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -2902000.00
OBIO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -112000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Receivables: 89000.00
OBIO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 44000.00
OBIO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 83000.00
OBIO income_statement (quarterly, 2025-03-31) — Research And Development: 13482000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -328633000.00
OBIO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 16013000.00
OBIO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 6263000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Share Issued: 38312512.00
OBIO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2965000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 16857000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 16857000.00
OBIO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
OBIO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
OBIO balance_sheet (quarterly, 2025-03-31) — Total Assets: 59051000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 31195000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Total Debt: 16444000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 16857000.00
OBIO income_statement (quarterly, 2025-03-31) — Total Expenses: 19789000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 42194000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7148000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 26705000.00
OBIO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -18921000.00
OBIO income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -166000.00
OBIO balance_sheet (quarterly, 2025-03-31) — Trading Securities: 2495000.00
OBIO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
OBIO balance_sheet (quarterly, 2025-03-31) — Working Capital: 36414000.00
OBIO income_statement (quarterly, 2025-06-30) — +Operating Expense: 20117000.00
OBIO income_statement (quarterly, 2025-06-30) — +Total Revenue: 836000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5308000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 83000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1467000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 348271000.00
OBIO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 38392716.00
OBIO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.50
OBIO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 18348000.00
OBIO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -34000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1970000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 4000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 18749000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 33924000.00
OBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -428000.00
OBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 16356000.00
OBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -15527000.00
OBIO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -49000.00
OBIO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -135000.00
OBIO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -667000.00
OBIO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1090000.00
OBIO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 113000.00
OBIO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 6000.00
OBIO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 358000.00
OBIO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 6000.00
OBIO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 401000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Common Stock: 4000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 295000.00
OBIO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 46000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 4675000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Current Assets: 35882000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 642000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 642000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 4461000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 4461000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 17061000.00
OBIO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 81000.00
OBIO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 81000.00
OBIO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 38392716.00
OBIO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.50
OBIO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -19363000.00
OBIO income_statement (quarterly, 2025-06-30) — EBIT: -19327000.00
OBIO income_statement (quarterly, 2025-06-30) — EBITDA: -19246000.00
OBIO cash_flow (quarterly, 2025-06-30) — End Cash Position: 18749000.00
OBIO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -428000.00
OBIO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -15561000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 16000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4639000.00
OBIO income_statement (quarterly, 2025-06-30) — Gross Profit: 790000.00
OBIO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 364000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Inventory: 185000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 14679000.00
OBIO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 16356000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 2495000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2495000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Leases: 159000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1328000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 14384000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 15712000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 443000.00
OBIO income_statement (quarterly, 2025-06-30) — Net Income: -19363000.00
OBIO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -19363000.00
OBIO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -19363000.00
OBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -19363000.00
OBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -19363000.00
OBIO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -19363000.00
OBIO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -19363000.00
OBIO income_statement (quarterly, 2025-06-30) — Net Interest Income: -36000.00
OBIO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 16390000.00
OBIO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -36000.00
OBIO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -428000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Net PPE: 3172000.00
OBIO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -34000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 295000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 9568000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 9568000.00
OBIO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -19246000.00
OBIO income_statement (quarterly, 2025-06-30) — Normalized Income: -19363000.00
OBIO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -15527000.00
OBIO income_statement (quarterly, 2025-06-30) — Operating Income: -19327000.00
OBIO income_statement (quarterly, 2025-06-30) — Operating Revenue: 836000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 38643553.00
OBIO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1690000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 16000.00
OBIO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 147000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1276000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 189000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Other Properties: 4037000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 15175000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Payables: 5308000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 9983000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1975000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
OBIO income_statement (quarterly, 2025-06-30) — Pretax Income: -19363000.00
OBIO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
OBIO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
OBIO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
OBIO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -34000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Receivables: 83000.00
OBIO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 46000.00
OBIO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 81000.00
OBIO income_statement (quarterly, 2025-06-30) — Research And Development: 13853000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -347996000.00
OBIO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 16390000.00
OBIO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 6264000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Share Issued: 38643553.00
OBIO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3250000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 295000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 295000.00
OBIO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
OBIO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
OBIO balance_sheet (quarterly, 2025-06-30) — Total Assets: 42825000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 14679000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Total Debt: 16354000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 295000.00
OBIO income_statement (quarterly, 2025-06-30) — Total Expenses: 20163000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 42530000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 6943000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 25469000.00
OBIO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -19327000.00
OBIO income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 36000.00
OBIO balance_sheet (quarterly, 2025-06-30) — Trading Securities: 2495000.00
OBIO cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
OBIO balance_sheet (quarterly, 2025-06-30) — Working Capital: 18821000.00
OBIO income_statement (quarterly, 2025-09-30) — +Operating Expense: 21125000.00
OBIO income_statement (quarterly, 2025-09-30) — +Total Revenue: 861000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8473000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 52000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1548000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 412512000.00
OBIO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 52186503.00
OBIO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.40
OBIO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 18749000.00
OBIO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -310000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1831000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 6000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 42012000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 95820000.00
OBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 76397000.00
OBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -38584000.00
OBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -14550000.00
OBIO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -181000.00
OBIO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -139000.00
OBIO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -721000.00
OBIO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 3412000.00
OBIO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 139000.00
OBIO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 31000.00
OBIO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2541000.00
OBIO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 31000.00
OBIO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 23263000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Common Stock: 6000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 43739000.00
OBIO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 49000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 5013000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Current Assets: 97768000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 696000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 696000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 4649000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 4649000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 20655000.00
OBIO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 81000.00
OBIO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 81000.00
OBIO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 52186503.00
OBIO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.40
OBIO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -20828000.00
OBIO income_statement (quarterly, 2025-09-30) — EBIT: -20313000.00
OBIO income_statement (quarterly, 2025-09-30) — EBITDA: -20232000.00
OBIO cash_flow (quarterly, 2025-09-30) — End Cash Position: 42012000.00
OBIO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 76397000.00
OBIO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -14860000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 45000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4796000.00
OBIO income_statement (quarterly, 2025-09-30) — Gross Profit: 812000.00
OBIO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 364000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Inventory: 365000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 57943000.00
OBIO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -38584000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 2495000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2495000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Leases: 159000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1135000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 14204000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 15339000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 444000.00
OBIO income_statement (quarterly, 2025-09-30) — Net Income: -20828000.00
OBIO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -20828000.00
OBIO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -20828000.00
OBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -20828000.00
OBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -20828000.00
OBIO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -20828000.00
OBIO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -20828000.00
OBIO income_statement (quarterly, 2025-09-30) — Net Interest Income: -515000.00
OBIO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -38274000.00
OBIO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -515000.00
OBIO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 18617000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Net PPE: 3248000.00
OBIO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -310000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 43739000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 8659000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 8659000.00
OBIO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -20232000.00
OBIO income_statement (quarterly, 2025-09-30) — Normalized Income: -20828000.00
OBIO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -14550000.00
OBIO income_statement (quarterly, 2025-09-30) — Operating Income: -20313000.00
OBIO income_statement (quarterly, 2025-09-30) — Operating Revenue: 861000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 56464731.00
OBIO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1531000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 45000.00
OBIO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 643000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1296000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 16415000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Other Properties: 4193000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 53808000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Payables: 8473000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 13486000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1824000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
OBIO income_statement (quarterly, 2025-09-30) — Pretax Income: -20828000.00
OBIO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
OBIO balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
OBIO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -47781000.00
OBIO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -310000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Receivables: 52000.00
OBIO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 49000.00
OBIO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 81000.00
OBIO income_statement (quarterly, 2025-09-30) — Research And Development: 14027000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -368824000.00
OBIO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 9507000.00
OBIO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 7098000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Share Issued: 56464731.00
OBIO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3013000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 43739000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 43739000.00
OBIO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
OBIO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
OBIO balance_sheet (quarterly, 2025-09-30) — Total Assets: 104807000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 57943000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Total Debt: 16035000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 43739000.00
OBIO income_statement (quarterly, 2025-09-30) — Total Expenses: 21174000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 61068000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 7039000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 40413000.00
OBIO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -20313000.00
OBIO income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 515000.00
OBIO balance_sheet (quarterly, 2025-09-30) — Trading Securities: 2495000.00
OBIO cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
OBIO balance_sheet (quarterly, 2025-09-30) — Working Capital: 77113000.00
OBIO income_statement (annual, 2025-12-31) — +Operating Expense: 85099000.00
OBIO income_statement (quarterly, 2025-12-31) — +Operating Expense: 24112000.00
OBIO income_statement (annual, 2025-12-31) — +Total Revenue: 110598.84
OBIO income_statement (quarterly, 2025-12-31) — +Total Revenue: 102126.05
OBIO balance_sheet (annual, 2025-12-31) — Accounts Payable: 6095000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 6095000.00
OBIO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 95000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 95000.00
OBIO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1631000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1631000.00
OBIO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 416083000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 416083000.00
OBIO income_statement (annual, 2025-12-31) — Basic Average Shares: 47747078.00
OBIO income_statement (annual, 2025-12-31) — Basic EPS: -1.11
OBIO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 22261000.00
OBIO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 42012000.00
OBIO cash_flow (annual, 2025-12-31) — Capital Expenditure: -489000.00
OBIO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -33000.00
OBIO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1687000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1687000.00
OBIO balance_sheet (annual, 2025-12-31) — Capital Stock: 6000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 6000.00
OBIO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 34690000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 34690000.00
OBIO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 106512000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 106512000.00
OBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 88333000.00
OBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 12660000.00
OBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -26941000.00
OBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -17712000.00
OBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -48963000.00
OBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2270000.00
OBIO cash_flow (annual, 2025-12-31) — Change In Inventory: -137000.00
OBIO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 55000.00
OBIO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -550000.00
OBIO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -144000.00
OBIO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -15428000.00
OBIO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -13308000.00
OBIO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 4866000.00
OBIO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 566000.00
OBIO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 880000.00
OBIO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 593000.00
OBIO cash_flow (annual, 2025-12-31) — Change In Receivables: -3000.00
OBIO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -43000.00
OBIO cash_flow (annual, 2025-12-31) — Change In Working Capital: -10372000.00
OBIO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -12281000.00
OBIO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -3000.00
OBIO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -43000.00
OBIO cash_flow (annual, 2025-12-31) — Changes In Cash: 12429000.00
OBIO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -7322000.00
OBIO balance_sheet (annual, 2025-12-31) — Common Stock: 6000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Common Stock: 6000.00
OBIO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 53570000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 53570000.00
OBIO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 59323000.00
OBIO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1543000.00
OBIO income_statement (annual, 2025-12-31) — Cost Of Revenue: 190000.00
OBIO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 51000.00
OBIO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 5730000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 5730000.00
OBIO balance_sheet (annual, 2025-12-31) — Current Assets: 107911000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Current Assets: 107911000.00
OBIO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 751000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 751000.00
OBIO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 751000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 751000.00
OBIO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 0.00
OBIO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 0.00
OBIO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 0.00
OBIO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 0.00
OBIO balance_sheet (annual, 2025-12-31) — Current Liabilities: 16736000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 16736000.00
OBIO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 327000.00
OBIO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 82000.00
OBIO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 327000.00
OBIO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 82000.00
OBIO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 2749000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 2749000.00
OBIO income_statement (annual, 2025-12-31) — Diluted Average Shares: 47747078.00
OBIO income_statement (annual, 2025-12-31) — Diluted EPS: -1.11
OBIO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -52955000.00
OBIO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 5991000.00
OBIO income_statement (annual, 2025-12-31) — EBIT: -51553000.00
OBIO income_statement (quarterly, 2025-12-31) — EBIT: 7008000.00
OBIO income_statement (annual, 2025-12-31) — EBITDA: -51226000.00
OBIO income_statement (quarterly, 2025-12-31) — EBITDA: 7090000.00
OBIO cash_flow (annual, 2025-12-31) — End Cash Position: 34690000.00
OBIO cash_flow (quarterly, 2025-12-31) — End Cash Position: 34690000.00
OBIO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 88333000.00
OBIO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 12660000.00
OBIO cash_flow (annual, 2025-12-31) — Free Cash Flow: -49452000.00
OBIO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2303000.00
OBIO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -254000.00
OBIO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 254000.00
OBIO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 60000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 60000.00
OBIO balance_sheet (annual, 2025-12-31) — Gross PPE: 4842000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4842000.00
OBIO income_statement (annual, 2025-12-31) — Gross Profit: 950652.30
OBIO income_statement (quarterly, 2025-12-31) — Gross Profit: 950652.30
OBIO income_statement (annual, 2025-12-31) — Interest Expense: 1148000.00
OBIO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1148000.00
OBIO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1447000.00
OBIO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 361000.00
OBIO balance_sheet (annual, 2025-12-31) — Inventory: 310000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Inventory: 310000.00
OBIO balance_sheet (annual, 2025-12-31) — Invested Capital: 67838000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 67838000.00
OBIO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -26941000.00
OBIO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -17712000.00
OBIO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 2495000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 2495000.00
OBIO balance_sheet (annual, 2025-12-31) — Investments And Advances: 2495000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2495000.00
OBIO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 71880000.00
OBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 14100000.00
OBIO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
OBIO balance_sheet (annual, 2025-12-31) — Leases: 159000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Leases: 159000.00
OBIO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 936000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 936000.00
OBIO balance_sheet (annual, 2025-12-31) — Long Term Debt: 14268000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 14268000.00
OBIO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 15204000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 15204000.00
OBIO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
OBIO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 444000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 444000.00
OBIO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 59323000.00
OBIO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1543000.00
OBIO income_statement (annual, 2025-12-31) — Net Income: -52701000.00
OBIO income_statement (quarterly, 2025-12-31) — Net Income: 6245000.00
OBIO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -52955000.00
OBIO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 5991000.00
OBIO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -52701000.00
OBIO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 6245000.00
OBIO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -52701000.00
OBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6245000.00
OBIO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -52701000.00
OBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6245000.00
OBIO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -52701000.00
OBIO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 6245000.00
OBIO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -52701000.00
OBIO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 6245000.00
OBIO income_statement (annual, 2025-12-31) — Net Interest Income: -1148000.00
OBIO income_statement (quarterly, 2025-12-31) — Net Interest Income: -763000.00
OBIO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -26452000.00
OBIO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -17679000.00
OBIO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
OBIO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
OBIO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1148000.00
OBIO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -763000.00
OBIO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 16362000.00
OBIO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1440000.00
OBIO balance_sheet (annual, 2025-12-31) — Net PPE: 3211000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Net PPE: 3211000.00
OBIO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -489000.00
OBIO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -33000.00
OBIO cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 12557000.00
OBIO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 53570000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 53570000.00
OBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 0.00
OBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 0.00
OBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 0.00
OBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 0.00
OBIO income_statement (annual, 2025-12-31) — Normalized EBITDA: -51480000.00
OBIO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7090000.00
OBIO income_statement (annual, 2025-12-31) — Normalized Income: -52955000.00
OBIO income_statement (quarterly, 2025-12-31) — Normalized Income: 6245000.00
OBIO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -48963000.00
OBIO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -2270000.00
OBIO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -254000.00
OBIO income_statement (annual, 2025-12-31) — Operating Income: -23161347.70
OBIO income_statement (quarterly, 2025-12-31) — Operating Income: -23161347.70
OBIO income_statement (annual, 2025-12-31) — Operating Revenue: 110598.84
OBIO income_statement (quarterly, 2025-12-31) — Operating Revenue: 102126.05
OBIO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 57032963.00
OBIO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 57032963.00
OBIO balance_sheet (annual, 2025-12-31) — Other Current Assets: 994000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 994000.00
OBIO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 60000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 60000.00
OBIO income_statement (annual, 2025-12-31) — Other Income Expense: 254000.00
OBIO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 2059000.00
OBIO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1188000.00
OBIO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1240000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1240000.00
OBIO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 16790000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 16790000.00
OBIO balance_sheet (annual, 2025-12-31) — Other Properties: 4239000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Other Properties: 4239000.00
OBIO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 71822000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 71822000.00
OBIO balance_sheet (annual, 2025-12-31) — Payables: 6095000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Payables: 6095000.00
OBIO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 11825000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 11825000.00
OBIO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4160000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4160000.00
OBIO balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 9808000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 9808000.00
OBIO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
OBIO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
OBIO income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 254000.00
OBIO cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 12557000.00
OBIO income_statement (annual, 2025-12-31) — Pretax Income: -52701000.00
OBIO income_statement (quarterly, 2025-12-31) — Pretax Income: 6245000.00
OBIO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 91000.00
OBIO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
OBIO balance_sheet (annual, 2025-12-31) — Properties: 0.00
OBIO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
OBIO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -76312000.00
OBIO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -25629000.00
OBIO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -489000.00
OBIO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -33000.00
OBIO balance_sheet (annual, 2025-12-31) — Receivables: 95000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Receivables: 95000.00
OBIO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 190000.00
OBIO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 51000.00
OBIO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 327000.00
OBIO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 82000.00
OBIO income_statement (annual, 2025-12-31) — Research And Development: 58185000.00
OBIO income_statement (quarterly, 2025-12-31) — Research And Development: 16823000.00
OBIO balance_sheet (annual, 2025-12-31) — Retained Earnings: -362579000.00
OBIO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -362579000.00
OBIO cash_flow (annual, 2025-12-31) — Sale Of Investment: 49860000.00
OBIO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 7950000.00
OBIO income_statement (annual, 2025-12-31) — Selling General And Administration: 26914000.00